United States · 
Who invested in Nuvalent?
Nuvalent's investors include Fidelity, Wellington Management, Deerfield, Janus Henderson Investors and Bain Capital Life Sciences.
United States · Funded startup
Who invested in Nuvalent
Funding summaryUpdated 26 Oct 2026
$500Mraised across 1 round since 2025, from 1 source
- Latest round
- Secondary, $500MNov 2025
- Investors
- 5
The rounds
- Nov 2025Secondary$500M
Source recorded
Founders and team
From Nuvalent's own website and the SEC filings it signed: 5 on the team.
- Ruth AdamsSenior Vice President, Clinical Operations
- Clinical Supply ChainChief Development Officer
- Sarah PileekiChief Scientific Officer
- Alex Porter BalcomExecutive Officeri
- R. Porter JamesExecutive Officer, Directori
On the board, as filediAndrew Porter HackCameron Porter WheelerGary Porter GillilandJoseph Porter PearlbergMatthew Porter ShairRobert Porter Jackson
Everyone who backed them
FidelityVC firm1round
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nuvalent
How much has Nuvalent raised?
Nuvalent has raised $500M across 1 round since 2025.
When did Nuvalent last raise?
Nuvalent's most recent round was a Secondary of $500M in Nov 2025.
What was Nuvalent's biggest round?
Its most recent round, $500M in Nov 2025, is also its largest on record.
Who backed Nuvalent first?
Nuvalent's first round on record, in Nov 2025, was backed by Fidelity, Wellington Management and Deerfield and 2 others.
What stage is Nuvalent at?
Nuvalent's latest named round is a Secondary, in Nov 2025.
Where is Nuvalent based?
Nuvalent is based in the United States.
Companies like Nuvalent
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.